본문 바로가기
오늘 하루 보지 않기
MEDIA 1 페이지
Company
Overview
History
Global Network
MEDIA
NEWS
Video Advertising
PR Video
Contact Us
Technology
NK Cells
SuperNK®
NK Vue®
R&D Facilities
Research study and Product Resources
Business
Immunotherapy
Anti-cancer Immunotherapy
Pipeline
Diagnostic Kits
NK Cell Activity Test
NK Vue® Kit
NK Cell Activity Test FAQs
NK365
Dietary Supplements
Global Partnership
Research Reagents
Pet Business
NK PUPPY
NK365 Pet
Investor
Notices
IR Resources
Order NK365
SuperNK®
NK Vue®
NK365
NKMAXBio
NKGen Biotech
EN
Korean
English
Chinese
Japanese
전체메뉴보기
Company
Overview
History
Global Network
MEDIA
NEWS
Video Advertising
PR Video
Contact Us
Technology
NK Cells
SuperNK®
NK Vue®
R&D Facilities
Research study and Product Resources
Business
Immunotherapy
Anti-cancer Immunotherapy
Pipeline
Diagnostic Kits
NK Cell Activity Test
NK Vue® Kit
NK Cell Activity Test FAQs
NK365
Dietary Supplements
Global Partnership
Research Reagents
Pet Business
NK PUPPY
NK365 Pet
Investor
Notices
IR Resources
company
HOME
Company
Company
Technology
Business
Investor
MEDIA
Overview
History
Global Network
MEDIA
Contact Us
MEDIA
NEWS
Video Advertising
PR Video
TOTAL
5
게시물 검색
검색대상
subject
content
subject+content
검색어
필수
검색하기
MEDIA List
No.
Title
Autor
Date
View
5
NKMax America to Present at the Upcoming NIH-AACR Cancer, Autoimmunity, and Immunology Conference
NKMAX
03-18
10231
4
NKMax America Announces Executive Advisory Board
NKMAX
11-13
8356
3
NKMax America Announces New cGMP Manufacturing Facility for Production of SNK Cell Therapy
NKMAX
09-10
12869
2
NKMax America Initiates Phase I Clinical Trial of SNK in Patients with Psoriasis in Mexico
NKMAX
09-10
4716
1
NKMax America Doses First Subject in Phase I Trial of SNK in Patients with Refractory Cancer
NKMAX
09-10
3918
Move to Top